IRCT20220620055230N1
Completed
Phase 3
A Double blind, Randomized, Comparative study of the Efficacy and Safety of Botulinum Toxin type A Masport with commercial brand Dysport in the treatment of Primary Axillary Hyperhidrosis
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults aged between 18 to 65 years who have a sweating rate of 50 mg per minute or higher.
Exclusion Criteria
- •secondary Hyperhidrosis due to systemic problems.
- •people who have taken Aminoglycosides in the last three weeks.
- •people who have had botulinum toxin injection in the past year.
- •people with Neuromuscellar diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
COMPARING THE EFFECTS OF TWO PAIN RELIEVING MEDICINES ON CHILDREN UNDERGOING THROAT SURGERIESHealth Condition 1: O- Medical and SurgicalCTRI/2020/03/023680OT APPLICABLE
Completed
Not Applicable
A Randomized, Double Blind, Comparative Study Of STATUS D3Ⓡ (vitamin D3) Versus Placebo In Children Aged Between 7 And 15 Years Old to prevent infectious diseases including influenza and to improve atopic dermatitiselementary shool, junior high school childrenJPRN-UMIN000001373Jikei University School of Medicine300
Recruiting
Phase 2
Clinical trial on detergent powder in healthy human volunteersCTRI/2023/12/060978ILEVER INDUSTRIES PRIVATE LIMITED
Recruiting
Phase 3
Skin irritancy potential of detergents in healthy human volunteersCTRI/2024/04/065908nilever Industries Private Limited
Completed
Phase 3
Clinical trial on detergents in healthy human volunteersCTRI/2023/07/055614nilever Industries Private Limited24